Anokion is a biotechnology company with offices in Lausanne, Switzerland and Cambridge, Massachusetts, USA, specializing in immune tolerance. Their innovative science platform focuses on developing therapies for autoimmune diseases such as celiac disease and multiple sclerosis.
With a strong leadership team and a robust pipeline of potential treatments, Anokion is at the forefront of research and development in the field of immune tolerance. Their cutting-edge approach, including the use of SynCeD and ACeD-it technologies, aims to revolutionize the way autoimmune diseases are treated, offering hope to patients worldwide.
Generated from the website